The Big Island now has another way to help combat COVID-19.
Queen’s North Hawai’i Community Hospital in Waimea is now providing the preventative medication Evusheld, which is a monoclonal antibody that helps prevent COVID infections. It is for people who are not infected but considered at a high risk of contracting COVID and might not have developed strong antibodies from vaccination or were unable to be vaccinated.
Examples of high-risk conditions include organ transplant, HIV, active cancer and rheumatology patients on immune suppressive drugs.
Evusheld is not for people who can be vaccinated but are refusing vaccination, nor is it for people with normal immune systems but worried their immunity is low. The medication is given as a simple injection and is being provided in the QNHCH Infusion Center.
ARTICLE CONTINUES BELOW AD
ARTICLE CONTINUES BELOW AD
Anyone interested in Evusheld should contact their health care provider to learn more about the medication.
To learn more about Queen’s North Hawai’i Community Hospital, click here.
This comments section is a public community forum for the purpose of free expression. Although Big Island Now encourages respectful communication only, some content may be considered offensive. Please view at your own discretion. View Comments
